A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

Launched by RU-ZHOU CAI · Jul 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how portal vein thrombosis (PVT) affects the success of liver transplants. PVT is a condition where a blood clot blocks the portal vein, which carries blood to the liver. The researchers want to understand how common PVT is among people who need a liver transplant, what factors may increase the risk of developing it, and how having PVT before surgery might influence the overall outcomes of the transplant.

If you are at least 18 years old and are scheduled for a liver transplant, you might be eligible to participate in this study. However, if you have had a previous transplant or are receiving a transplant of multiple organs, you would not qualify. Participants will be grouped based on whether they have PVT or not, and the researchers will collect and compare data from both groups. This information may help improve how doctors predict and manage PVT in patients who are preparing for a liver transplant.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Liver transplantation recipients
• • 2. Aged 18 years or older.
• Exclusion Criteria:
• • 1. Retransplantation
• • 2. Multi-organ transplantation
• • 3. Portal vein tumor thrombus